English
  1. Home
  2. Stocks
  3. Supriya Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Supriya Lifescience Share Price Supriya Lifescience

    Small Cap
    ₹378.15
    +9.5 (2.58%)
    12 May, 2024 22:13 BSE: 543434 NSE: SUPRIYAISIN: INE07RO01027

    Start SIP in Supriya Lifescience

    Start SIP

    Supriya Lifescience Performance

    Day Range

    • Low 361
    • High 379
    ₹ 378

    52 Week Range

    • Low 220
    • High 424
    ₹ 378
    • Open Price371
    • Previous Close369
    • Volume223130

    Supriya Lifescience Share Price

    • Over 1 Month -0.66%
    • Over 3 Month +10.36%
    • Over 6 Month +48.44%
    • Over 1 Year +69.8%

    Supriya Lifescience Key Statistics

    P/E Ratio 25.3
    PEG Ratio 1.1
    Market Cap Cr 3,044
    Price to Book Ratio 4.4
    EPS 11.2
    Dividend 0.2
    Relative Strength Index 48.28
    Money Flow Index 79.14
    MACD Signal 10.97
    Average True Range 18.09
    Supriya Lifescience Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 140140132142
    Operating Expenses Qtr Cr 991088887
    Operating Profit Qtr Cr 41324455
    Depreciation Qtr Cr 4443
    Interest Qtr Cr 0011
    Tax Qtr Cr 1061415
    Net Profit Qtr Cr 30242938
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 470
    Operating Expenses Annual Cr 332
    Operating Profit Annual in Cr 129
    Depreciation Cr 12
    Interest Annual Cr 3
    Tax Annual Cr 34
    Net Profit Annual Cr 90
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 66
    Cash from Investing Activity Annual Cr -133
    Cash from Financing Annual Activity Cr -3
    Net Cash Flow Annual Cr -70
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 699
    Fixed Assets Annual Cr 329
    Total Non Current Assets Annual Cr 355
    Total Current Assets Annual Cr 465
    Total Assets Annual Cr 820
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 87
    ROE Annual % 13
    ROCE Annual % 17
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 30
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in Supriya Lifescience

    Supriya Lifescience Technicals

    EMA & SMA

    Current Price
    ₹378.15
    +9.5 (2.58%)
    pointer
    • Bullish Moving Average
    • ___
    • 7
    • Bearish Moving Average
    • ___
    • 9
    • 20 Day
    • ₹386.42
    • 50 Day
    • ₹368.59
    • 100 Day
    • ₹344.54
    • 200 Day
    • ₹317.35
    • 20 Day
    • ₹389.23
    • 50 Day
    • ₹365.20
    • 100 Day
    • ₹340.25
    • 200 Day
    • ₹303.18

    Supriya Lifescience Resistance and Support

    PIVOT
    ₹372.65
    Resistance
    First Resistance 384.50
    Second Resistance 390.85
    Third Resistance 402.70
    RSI 48.28
    MFI 79.14
    MACD Single Line 10.97
    MACD 6.36
    Support
    First Resistance 366.30
    Second Resistance 354.45
    Third Resistance 348.10

    Supriya Lifescience Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 251,143 8,918,088 35.51
    Week 318,767 13,181,024 41.35
    1 Month 501,293 18,357,367 36.62
    6 Month 617,867 22,811,646 36.92

    Supriya Lifescience Result Highlights

    Supriya Lifescience Synopsis

    NSE-Medical-Supplies

    Supriya Lifescience is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 460.94 Cr. and Equity Capital is Rs. 16.10 Cr. for the Year ended 31/03/2023. Supriya Lifescience Ltd. is a Public Limited Listed company incorporated on 26/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH2008PLC180452 and registration number is 180452.
    Market Cap 3,043
    Sales 554
    Shares in Float 2.58
    No of funds 38
    Yield 0.15
    Book Value 4.35
    U/D Vol ratio 1.5
    LTDebt / Equity
    Alpha 0.17
    Beta 0.97

    Supriya Lifescience

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 68.3%68.3%68.3%68.3%
    Mutual Funds 0.05%0.04%1.74%2.14%
    Insurance Companies 3.71%3.81%3.89%3.86%
    Foreign Portfolio Investors 5.37%4.56%5.35%5.73%
    Individual Investors 17.06%17.51%16.1%15.4%
    Others 5.51%5.78%4.62%4.57%

    Supriya Lifescience Management

    Name Designation
    Mr. Satish Waman Wagh Chairman & Managing Director
    Ms. Smita Satish Wagh Whole Time Director
    Ms. Saloni Satish Wagh Whole Time Director
    Ms. Shivani Satish Wagh Whole Time Director
    Mr. Balasahab Gulabrao Sawant Whole Time Director
    Mr. Kedar Shankar Karmarkar Independent Director
    Mr. Bhairav Manojbhai Chokshi Independent Director
    Mr. Dileep Kumar Jain Independent Director
    Mr. Dinesh Navnitlal Modi Independent Director
    Ms. Neelam Yashpal Arora Independent Director

    Supriya Lifescience Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Supriya Lifescience Corporate Action

    Date Purpose Remarks
    2024-02-07 Quarterly Results
    2023-11-07 Quarterly Results
    2023-08-03 Quarterly Results
    2023-05-26 Audited Results & Final Dividend
    2023-02-14 Quarterly Results

    Supriya Lifescience MF Shareholding

    Name Amount(cr)
    Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 815
    Groww Nifty Total Market Index Fund Regular Growth 113

    Supriya Lifescience FAQs

    What is Share Price of Supriya Lifescience ?

    Supriya Lifescience share price is ₹378 As on 12 May, 2024 | 21:59

    What is the Market Cap of Supriya Lifescience ?

    The Market Cap of Supriya Lifescience is ₹3043.5 Cr As on 12 May, 2024 | 21:59

    What is the P/E ratio of Supriya Lifescience ?

    The P/E ratio of Supriya Lifescience is 25.3 As on 12 May, 2024 | 21:59

    What is the PB ratio of Supriya Lifescience ?

    The PB ratio of Supriya Lifescience is 4.4 As on 12 May, 2024 | 21:59

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.